FineMark National Bank & Trust cut its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 13.9% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,596 shares of the company’s stock after selling 579 shares during the period. FineMark National Bank & Trust’s holdings in Express Scripts Holding were worth $230,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in ESRX. Dubuque Bank & Trust Co. boosted its stake in shares of Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock valued at $116,000 after buying an additional 608 shares in the last quarter. TrimTabs Asset Management LLC acquired a new stake in shares of Express Scripts Holding during the first quarter valued at about $121,000. Capital Analysts LLC boosted its stake in shares of Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock valued at $124,000 after buying an additional 100 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after buying an additional 145 shares in the last quarter. Finally, FNY Partners Fund LP acquired a new stake in shares of Express Scripts Holding during the first quarter valued at about $138,000. Institutional investors and hedge funds own 90.24% of the company’s stock.

Express Scripts Holding Company (ESRX) opened at 61.04 on Friday. The firm has a 50-day moving average of $62.32 and a 200-day moving average of $64.26. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.61. The company has a market capitalization of $35.25 billion, a P/E ratio of 10.59 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.57 EPS. Analysts anticipate that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/18/express-scripts-holding-company-esrx-shares-sold-by-finemark-national-bank-trust.html.

Several brokerages have recently issued reports on ESRX. UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the company a “hold” rating in a research report on Tuesday, April 25th. Jefferies Group LLC set a $88.00 target price on shares of Express Scripts Holding and gave the company a “buy” rating in a research report on Thursday, April 20th. Morgan Stanley decreased their target price on shares of Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 26th. BidaskClub upgraded shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, Robert W. Baird decreased their target price on shares of Express Scripts Holding from $73.00 to $53.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 25th. Four equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $71.17.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.